Skip to main content
NKGen Biotech, Inc. (NKGN)
NASDAQ: NKGN · IEX Real-Time Price · USD
1.460
-0.050 (-3.31%)
At close: May 1, 2024, 4:00 PM
1.500
+0.040 (2.74%)
After-hours: May 1, 2024, 7:55 PM EDT

NKGen Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current202320222021
Market Capitalization
3360213208
Market Cap Growth
--71.80%2.68%-
Enterprise Value
5380225259
PE Ratio
-0.73-0.73-7.98-8.93
PS Ratio
--2772.03487.98
PB Ratio
-1.03-1.03136.56-5.46
P/FCF Ratio
-2.74-2.74-9.39-10.39
P/OCF Ratio
-2.74-2.74-9.46-10.63
EV/Sales Ratio
--2926.79609.15
EV/EBITDA Ratio
-0.99-0.99-9.89-12.54
EV/EBIT Ratio
-0.97-0.97-9.22-11.82
EV/FCF Ratio
-3.63-3.63-9.92-12.97
Debt / Equity Ratio
-0.34-0.347.70-1.37
Debt / EBITDA Ratio
-0.25-0.25-0.53-2.51
Debt / FCF Ratio
-0.91-0.91-0.53-2.60
Quick Ratio
0.010.010.010.01
Current Ratio
0.050.050.020.01
Asset Turnover
000.000.01
Interest Coverage
-110.34-110.34-10.60-16.69
Return on Equity (ROE)
283.20%283.20%692.90%218.40%
Return on Assets (ROA)
-416.00%-416.00%-19.90%-25.30%
Return on Capital (ROIC)
76.72%76.72%-179.05%-157.66%
Earnings Yield
-249.14%-137.81%-12.53%-11.19%
FCF Yield
-66.06%-36.54%-10.64%-9.62%
Buyback Yield / Dilution
-142.70%-142.70%55.39%-
Total Shareholder Return
-142.70%-142.70%55.39%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).